A prototype antifungal contact lens

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 9, 2011, Pages 6286-6291

  Ciolino, Joseph B ^a,b   Hudson, Sarah P ^c,d   Mobbs, Ashley N ^c   Hoare, Todd R ^c,e   Iwata, Naomi G ^c,f   Fink, Gerald R ^g   Kohane, Daniel S ^b  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c Massachusetts Institute of Technology Cambridge   (United States)

^d UNIVERSITY OF LIMERICK   (Ireland)

^e MCMASTER UNIVERSITY   (Canada)

^f WELLESLEY COLLEGE   (United States)

^g WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECONAZOLE; POLYGLACTIN; POLYMACON; ANTIFUNGAL AGENT; BIOMATERIAL; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTACT LENS; CONTROLLED STUDY; DRUG RELEASE; EQUIPMENT DESIGN; FILM COATING; FREEZE DRYING; FUNGAL EYE INFECTION; FUNGICIDAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAMAN SPECTROMETRY; SCANNING ELECTRON MICROSCOPY; ULTRAVIOLET RADIATION; CHEMISTRY; CORNEA ULCER; DESICCATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; HYDROPHILIC CONTACT LENS; ULTRASTRUCTURE;

ANTIFUNGAL AGENTS; BIOCOMPATIBLE MATERIALS; CANDIDA ALBICANS; CONTACT LENSES, HYDROPHILIC; CORNEAL ULCER; DESICCATION; DRUG DELIVERY SYSTEMS; ECONAZOLE; EQUIPMENT DESIGN; LACTIC ACID; MICROSCOPY, ELECTRON, SCANNING; POLYGLYCOLIC ACID; POLYHYDROXYETHYL METHACRYLATE; SPECTRUM ANALYSIS, RAMAN;

EID: 80053435462     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-6935     Document Type: Article

References (39)

1. Ou JI, Acharya NR. Epidemiology and treatment of fungal corneal ulcers. Int Ophthalmol Clin. 2007;47(3):7-16.
2. Khor WB, Aung T, Saw SM, et al. An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. JAMA. 2006; 295(24):2867-2873.
3. Chang DC, Grant GB, O'Donnell K, et al. Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. JAMA. 2006;296(8):953-963.
4. Jurkunas U, Behlau I, Colby K. Fungal keratitis: changing pathogens and risk factors. Cornea. 2009;28(6):638-643.
5. Vemuganti GK, Garg P, Gopinathan U, et al. Evaluation of agent and host factors in progression of mycotic keratitis: a histologic and microbiologic study of 167 corneal buttons. Ophthalmology. 2002;109(8):1538-1546.
6. Ghate D, Edelhauser HF. Barriers to glaucoma drug delivery. J Glaucoma. 2008;17(2):147-156.
7. Jarvinen KJT, Urtti A. Ocular absorption following topical delivery. Adv Drug Deliv Rev. 1996;16:3-19.
8. Lalitha P, Shapiro BL, Srinivasan M, et al. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis. Arch Ophthalmol. 2007;125(6):789-793.
9. Manzouri B, Vafidis GC, Wyse RK. Pharmacotherapy of fungal eye infections. Expert Opin Pharmacother. 2001;11:1849-1857.
10. O'Day DM, Ray WA, Head WS, Robinson RD. Influence of the corneal epithelium on the efficacy of topical antifungal agents. Invest Ophthalmol Vis Sci. 1984;25(7):855-859.
11. Johns KJ, O'Day DM. Pharmacologic management of keratomycoses. Surv Ophthalmol. 1988;33(3):178-188.
12. Prajna NV, John RK, Nirmalan PK, Lalitha P, Srinivasan M. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. Br J Ophthalmol. 2003; 87(10):1235-1237.
13. Thomas PA. Fungal infections of the cornea. Eye (Lond). 2003; 17(8):852-862.
14. Wichterle OLD. Hydrophilic gels for biological use. Nature. 1960; 185:117-118.
15. Ciolino JB, Dohlman CH, Kohane DS. Contact lenses for drug delivery. Semin Ophthalmol. 2009;24(3):156-160.
16. Gulsen D, Chauhan A. Ophthalmic drug delivery through contact lenses. Invest Ophthalmol Vis Sci. 2004;45(7):2342-2347.
17. Ciolino JB, Hoare TR, Iwata NG, et al. A drug-eluting contact lens. Invest Ophthalmol Vis Sci. 2009;50(7):3346-3352.
18. Galarreta DJ, Tuft SJ, Ramsay A, Dart JK. Fungal keratitis in London: microbiological and clinical evaluation. Cornea. 2007;26(9):1082-1086.
19. Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials. 2000;21(23):2475-2490.
20. Wang G, Tucker IG, Roberts MS, Hirst LW. In vitro and in vivo evaluation in rabbits of a controlled release 5-fluorouracil subconjunctival implant based on poly(D, L-lactide-co-glycolide). Pharm Res. 1006;13(7):1059-1064.
21. Sakurai E, Matsuda Y, Ozeki H, Kunou N, Nakajima K, Ogura Y. Scleral plug of biodegradable polymers containing ganciclovir for experimental cytomegalovirus retinitis. Invest Ophthalmol Vis Sci. 2001;42(9):2043-2048.
22. Herrero-Vanrell R, Ramirez L, Fernandez-Carballido A, Refojo MF. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration: encapsulation technique, in vitro release profiles, and sterilization process. Pharm Res. 2000;(10): 1323-1328.
23. ISO 10993 Biological evaluation of medical devices. Part 12: Sample preparation and reference materials. Geneva, Switzerland: International Standards Organization; 2007.
24. ISO 11986 Ophthalmic optics: contact lenses and contact lens care products-determination of preservative uptake and release. Geneva, Switzerland: International Standards Organization; 2010.
25. Standard Practice for Extraction of Medical Plastics. Vol F619. Philadelphia: American Society for Testing and Materials; 2008.
26. Odds FC, Vranckx L, Woestenborghs F. Antifungal susceptibility testing of yeasts: evaluation of technical variables for test automation. Antimicrob Agents Chemother. 1995;39(9):2051-2060.
27. Schwartz B. The effect of lid closure upon the ocular temperature gradient. Invest Ophthalmol. 1964;3:100-106.
28. Ng EY, Ooi EH. Ocular surface temperature: a 3D FEM prediction using bioheat equation. Comput Biol Med. 2007;37(6):829-835.
29. Hudson SP, Langer R, Fink GR, Kohane DS. Injectable in situ cross-linking hydrogels for local antifungal therapy. Biomaterials. 2010;31(6):1444-1452.
30. Zumbuehl A, Ferreira L, Kuhn D, et al. Antifungal hydrogels. Proc Natl Acad Sci U S A. 2007;104(32):12994-12998.
31. O'Day DM. Selection of appropriate antifungal therapy. Cornea. 1987;6(4):238-245.
32. Loh AR, Hong K, Lee S, Mannis M, Acharya NR. Practice patterns in the management of fungal corneal ulcers. Cornea. 2009;28(8): 856-859.
33. Tuft SJ, Tullo AB. Fungal keratitis in the United Kingdom 2003-2005. Eye (Lond) 2009;23(6):1308-1313.
34. Oji EO, Clayton YM. The role of econazole in the management of oculomycosis. Int Ophthalmol. 1982;4(3):137-142.
35. Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res. 2004;21(2):191-200.
36. Bullock JD. Root cause analysis of the fusarium keratitis epidemic of 2004-2006 and prescriptions for preventing future epidemics. Trans Am Ophthalmol Soc. 2009;107:194-204.
37. http://www.fda.gov/CombinationProducts/AboutCombination Products/ucm118332.htm. Accessed February 2, 2011.
38. Ormerod LD. Causation and management of microbial keratitis in subtropical Africa. Ophthalmology. 1987;94(12):1662-1668.
39. Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN. The epidemiological features and laboratory results of fungal keratitis: a 10-year review at a referral eye care center in South India. Cornea. 2002;21(6):555-559.